Low-dose IL-2 for patients with systemic lupus erythematosus

被引：1
|
作者：
He, Jing [1 ]
Sun, Xiaolin [1 ]
Li, Zhanguo [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100044, Peoples R China
来源：
LANCET RHEUMATOLOGY | 2019年 / 1卷 / 04期
关键词：
SAFETY;
D O I：
10.1016/S2665-9913(19)30107-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E203 / E203
页数：1
相关论文
共 50 条
  • [31] Low-dose interleukin-2 for the treatment of systemic lupus erythematosus with recurrent rash
    Cheng, Jirong
    He, Miao
    Ma, Di
    Li, Xing
    Peng, Yuanhong
    RHEUMATOLOGY & AUTOIMMUNITY, 2024,
  • [32] Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus with a potential risk of deteriorating immunopathology
    Zhou, Pengcheng
    Chen, Jiali
    He, Jing
    Zheng, Ting
    Yunis, Joseph
    Makota, Victor
    Alexandre, Yannick O.
    Gong, Fang
    Zhang, Xia
    Xie, Wuxiang
    Li, Yuhui
    Shao, Miao
    Zhu, Yanshan
    Sinclair, Jane E.
    Miao, Miao
    Chen, Yaping
    Short, Kirsty R.
    Mueller, Scott N.
    Sun, Xiaolin
    Yu, Di
    Li, Zhanguo
    PLOS PATHOGENS, 2021, 17 (10)
  • [33] EFFICACY AND SAFETY OF LOW-DOSE IL-2 IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Su, Q. Y.
    Wang, X. M.
    Zhang, J. X.
    Bai, C. R.
    Chai, P. H.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1424 - 1425
  • [34] Low-Dose IL-2 Combined with Rapamycin Efficiently Promoted Disease Remission and Recovered the Balance of Th17/Regulatory T Cells in Patients with Refractory Systemic Lupus Erythematosus
    Jing, Xiaona
    Gao, Chong
    Hao, Liran
    Hao, Meihua
    Liang, Zhaoyun
    Li, Xiao-Feng
    Chen, Junwei
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [35] Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus
    Nagamine, Ayumu
    Takenaka, Miki
    Aomori, Tohru
    Okada, Yuko
    Hiromura, Keiju
    Nojima, Yoshihisa
    Araki, Takuya
    Nakamura, Tomonori
    Yamamoto, Koujirou
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (23) : 2072 - 2078
  • [36] EFFECT OF GENETIC POLYMORHISMS ON THE EFFICACY OF LOW-DOSE AZATHIOPRINE THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Aomori, T.
    Nagamine, A.
    Takenaka, M.
    Okada, Y.
    Hiromura, K.
    Nojima, Y.
    Araki, T.
    Nakamura, T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 67 - 67
  • [37] Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus
    Katsiari, CG
    Kyttaris, VC
    Juang, YT
    Tsokos, GC
    JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11): : 3193 - 3204
  • [38] Low-dose IL-2 therapy for autoimmune diseases
    Collison J.
    Nature Reviews Rheumatology, 2019, 15 (1) : 2 - 2
  • [39] Low-Dose Rituximab for Hemolytic Anemia Retreatment in a Patient With Systemic Lupus Erythematosus
    Rios-Fernandez, Raquel
    Callejas-Rubio, Jose-Luis
    Sanchez-Cano, Daniel
    Ortego-Centeno, Norberto
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (05) : E577 - E578
  • [40] Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goal
    Ji, Lanlan
    Gao, Dai
    Hao, Yanjie
    Huang, Hong
    Wang, Yu
    Deng, Xuerong
    Geng, Yan
    Zhang, Zhuoli
    RHEUMATOLOGY, 2022, 62 (01) : 181 - 189
12345